In the current study, the FOXP3+/CD8+ ratio was lower in NSCLC above the 50% PD-L1 cut-off point, but this result does not necessarily indicate a favorable TME for an adaptive anti-tumoral immune response due to the likelihood that most of those TIL are exhausted. Here, CD8A is linked to non-small cell lung carcinoma.